The PolyPeptide Group was founded in 1996 through the acquisition of the Peptech facility in Denmark, followed by the establishment of a US subsidiary in Torrance CA in 1997. In 2007 the US expanded with the acquisition of NEO MPS in San Diego, CA. Currently the US operation has about 175 employees with the GMP area being our biggest department.
Our peptides are used in the treatment of a large number of diseases such as Cancer, Diabetes and IBS.
Let’s recruit together and find your next colleague.